Pharma authorities keeping a close tab on Ukraine-Russia, a crucial market, to assess impact

Representative image

Indian pharmaceutical export apex bodies including the Pharmaceutical Export Promotion Council of India (Pharmexcil) are keeping a close tab on the evolving situation in Ukraine following the war with Russia to assess the impact it could have on the pharmaceutical exports from India.

“This is because Russia, Ukraine, and Uzbekistan are among the Commonwealth of Independent States (CIS) countries that have been on the top 30 destinations for the Indian pharmaceutical exports,” said Ravi Uday Bhaskar, director-general of Pharmexcil.

While it is too early to assess the likely adverse impact of the war on the Indian pharmaceutical exports to the CIS countries, Ukraine's situation is being closely monitored by the Indian authorities given its significance. “Ukraine saw a significant growth of 43.87% in pharmaceutical exports from India last fiscal (2020-21) at $181.56 million, up from $126.2 million in the previous fiscal (2019-20),” Uday Bhaskar told Moneycontrol.

The Indian pharmaceutical exports to the CIS countries saw a growth of 30.17% during the last fiscal at $1.17 billion, up from $905 million in 2019-20.